Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Westlake Village, California
- Most recent report
- 10-Q, filed Aug 5, 2026
- Incorporated
- Delaware
- Filings on record
- 836 filings
- On EDGAR
- CIK 1787306
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 32
News 8 of 73
Prospectuses and Registrations 8 of 26
- S-8 Registration statement for an employee plan Apr 21, 2026
- S-8 Registration statement for an employee plan Feb 25, 2026
- S-3ASR Automatic shelf registration Feb 25, 2026
- S-8 Registration statement for an employee plan Feb 25, 2025
- 424B5 Prospectus supplement for an offering Mar 1, 2024
- 424B5 Prospectus supplement for an offering Feb 28, 2024
- S-8 Registration statement for an employee plan Feb 27, 2024
- 424B5 Prospectus supplement for an offering Feb 8, 2024
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 21, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 18, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 18, 2023
Ownership 8 of 649
- 4 Insider reported a trade Aug 19, 2026
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Aug 13, 2026
- 144 Notice of a proposed sale of restricted stock Aug 11, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- 4 Insider reported a trade Aug 5, 2026
Other 8 of 44
- ARS Annual report sent to shareholders Apr 21, 2026
- UPLOAD Comment letter from SEC staff Dec 2, 2025
- CORRESP Reply to SEC staff Oct 10, 2025
- UPLOAD Comment letter from SEC staff Sep 15, 2025
- ARS Annual report sent to shareholders Apr 29, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- SC TO-I/A Amended filing Feb 15, 2024
- EFFECT Notice that a registration became effective Feb 8, 2024
Everything here comes from Arcutis Biotherapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.